Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancer | Zendy

Won Deok Joo | Zendy; Ji Young Lee | Zendy; Jong Hyeok Kim | Zendy; Hang Jo Yoo | Zendy; HyunJin Roh | Zendy; JeongYeol Park | Zendy; DaeYeon Kim | Zendy; YongMan Kim | Zendy; YoungTak Kim | Zendy; JooHyun Nam | Zendy

Open Access

Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancer

Author(s) -

Won Deok Joo,

Ji Young Lee,

Jong Hyeok Kim,

Hang Jo Yoo,

HyunJin Roh,

JeongYeol Park,

DaeYeon Kim,

YongMan Kim,

YoungTak Kim,

JooHyun Nam

Publication year - 2009

Publication title -

journal of gynecologic oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.358

H-Index - 37

eISSN - 2005-0399

pISSN - 2005-0380

DOI - 10.3802/jgo.2009.20.2.96

Subject(s) - carboplatin , medicine , taxane , paclitaxel , docetaxel , gemcitabine , cisplatin , chemotherapy , oncology , debulking , ovarian cancer , drug resistance , combination chemotherapy , cancer , urology , pharmacology , breast cancer , microbiology and biotechnology , biology

To evaluate the efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay (EDRA) in patients with epithelial ovarian cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research